The Food and Drug Administration (FDA), Center for Drug Evaluation and Research (CDER), Office of Medical Policy (OMP) is providing a grant opportunity to the Duke University’s Duke Translational Medicine Institute (DTMI) to enhance the quality and efficiency of clinical trials. The grant aims to support research initiatives that will contribute to advancements in clinical trial practices. Application deadline is on June 30, 2014.
Opportunity ID: 256108
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-FD-14-017 |
| Funding Opportunity Title: | Increasing the Quality and Efficiency of Clinical Trials (R18) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Food and Nutrition Health |
| Category Explanation: | – |
| Expected Number of Awards: | 1 |
| Assistance Listings: | 93.103 — Food and Drug Administration_Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 2 |
| Posted Date: | May 27, 2014 |
| Last Updated Date: | May 27, 2014 |
| Original Closing Date for Applications: | Jun 30, 2014 |
| Current Closing Date for Applications: | Jun 30, 2014 |
| Archive Date: | Jul 30, 2014 |
| Estimated Total Program Funding: | $7,500,000 |
| Award Ceiling: | $7,500,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Others (see text field entitled “Additional Information on Eligibility” for clarification) |
| Additional Information on Eligibility: | The following organization is eligible to apply:
Duke Translational Medicine Institute located within Duke University. |
Additional Information
| Agency Name: | Food and Drug Administration |
| Description: | The Food and Drug Administration (FDA), Center for Drug Evaluation and Research (CDER), Office of Medical Policy (OMP) is announcing its intent to accept and consider a single source application for the award of a grant to the Duke Universitys Duke Translational Medicine Institute (DTMI) to support increasing the quality and efficiency of clinical trials. |
| Link to Additional Information: | Federal Register Notice RFA-FD-14-017 |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Lisa Ko
Grants Management Specialist Email:lisa.ko@fda.hhs.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
| CFDA Number Update | May 27, 2014 | |
| May 27, 2014 |
DISPLAYING: Synopsis 2
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-FD-14-017 |
| Funding Opportunity Title: | Increasing the Quality and Efficiency of Clinical Trials (R18) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Food and Nutrition Health |
| Category Explanation: | – |
| Expected Number of Awards: | 1 |
| Assistance Listings: | 93.103 — Food and Drug Administration_Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 2 |
| Posted Date: | May 27, 2014 |
| Last Updated Date: | May 27, 2014 |
| Original Closing Date for Applications: | Jun 30, 2014 |
| Current Closing Date for Applications: | Jun 30, 2014 |
| Archive Date: | Jul 30, 2014 |
| Estimated Total Program Funding: | $7,500,000 |
| Award Ceiling: | $7,500,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Others (see text field entitled “Additional Information on Eligibility” for clarification) |
| Additional Information on Eligibility: | The following organization is eligible to apply:
Duke Translational Medicine Institute located within Duke University. |
Additional Information
| Agency Name: | Food and Drug Administration |
| Description: | The Food and Drug Administration (FDA), Center for Drug Evaluation and Research (CDER), Office of Medical Policy (OMP) is announcing its intent to accept and consider a single source application for the award of a grant to the Duke Universitys Duke Translational Medicine Institute (DTMI) to support increasing the quality and efficiency of clinical trials. |
| Link to Additional Information: | Federal Register Notice RFA-FD-14-017 |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Lisa Ko
Grants Management Specialist Email:lisa.ko@fda.hhs.gov |
DISPLAYING: Synopsis 1
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-FD-14-017 |
| Funding Opportunity Title: | Increasing the Quality and Efficiency of Clinical Trials (R18) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Food and Nutrition Health |
| Category Explanation: | – |
| Expected Number of Awards: | 1 |
| Assistance Listings: | [] |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | May 27, 2014 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | – |
| Current Closing Date for Applications: | Jun 30, 2014 |
| Archive Date: | Jul 30, 2014 |
| Estimated Total Program Funding: | $7,500,000 |
| Award Ceiling: | $7,500,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Others (see text field entitled “Additional Information on Eligibility” for clarification) |
| Additional Information on Eligibility: | The following organization is eligible to apply:
Duke Translational Medicine Institute located within Duke University. |
Additional Information
| Agency Name: | Food and Drug Administration |
| Description: | The Food and Drug Administration (FDA), Center for Drug Evaluation and Research (CDER), Office of Medical Policy (OMP) is announcing its intent to accept and consider a single source application for the award of a grant to the Duke Universitys Duke Translational Medicine Institute (DTMI) to support increasing the quality and efficiency of clinical trials. |
| Link to Additional Information: | Federal Register Notice RFA-FD-14-017 |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Lisa Ko
Grants Management Specialist Email:lisa.ko@fda.hhs.gov |
Related Documents
Folder 256108 Full Announcement-1 -> RFA-FD-14-017 CTTI sole source FINAL 5.9.14.pdf
Folder 256108 Full Announcement-1 -> SF424_RR_Guide_General_Adobe_VerC.pdf
Packages
| Agency Contact Information: | Lisa Ko Grants Management Specialist Email: lisa.ko@fda.hhs.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| 93.103 | PKG00197463 | May 27, 2014 | Jun 30, 2014 | View |
Package 1
Mandatory forms
256108 RR_SF424_2_0-2.0.pdf
256108 PHS398_ResearchPlan_2_0-2.0.pdf
256108 PHS398_CoverPageSupplement_2_0-2.0.pdf
256108 RR_Budget_1_3-1.3.pdf
256108 RR_KeyPersonExpanded_2_0-2.0.pdf
256108 RR_OtherProjectInfo_1_3-1.3.pdf
256108 PerformanceSite_2_0-2.0.pdf
Optional forms
256108 PlannedReport-1.0.pdf
256108 PHS398_CumulativeInclusionReport-1.0.pdf
256108 RR_SubawardBudget30_1_3-1.3.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
